Business News

Tag: Novartis

Health Innovation Study Technology The world

Pharming announces positive results of Phase II/III for the treatment of activated PI3K delta syndrome

Leiden, The Netherlands,Business News: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/NASDAQ: PHAR) announces positive results from the pivotal Phase II/III blinded

Read More

Share

You May Have Missed

Real Estate

Ohana Development Signs Multi-Year Partnership with West Ham United, Becomes Club’s Official Global Partner

Energy

Masdar and Silk Road Fund Sign Co-investment Agreement for Renewable Energy Projects

Awards

FTA earns Corporate Ethical Procurement and Supply Award for second time

Events

The “Crisis and Emergency” Authority to Host the World Crisis and Emergency Management Summit 2025 in April